Hepatitis C virus infection in Italian patients with hypogammaglobulinemia

Isabella Quinti, Franco Pandolfi, Roberto Paganelli, Antonello Giovannetti, Giovanna Sacco, Alessandra Oliva, Fernando Aiuti

Research output: Contribution to journalArticle

Abstract

We investigated the presence of hepatitis C virus (HCV) infection in 58 patients with humoral immunodeficiencies. Forty-three of these patients had common variable immunodeficiency (CVI), 2 had sporadic hyperimmunoglobulin M (HIM) syndrome, 2 had immunoglobulin C subclass deficiency, 4 had ataxia-telangiectasia (AT), and 7 had X-linked agammaglobulinemia (XLA). Patients with late-onset hypogammaglobulinemia (those with CVI, HIM, or immunoglobulin G subclass deficiency) had a 38.2% prevalence of HCV infection. In patients with XLA or AT, HCV infection was not detectable. Most of the HCV-infected patients had persistent viremia, with histologic findings of chronic hepatitis. Although patients positive for HCV ribonucleic acid (RNA) had received several lots of immunoglobulin, we were unable to detect any correlation between the time that alanine aminotransferase levels increased and the time that intravenous immunoglobulin therapy was given, except in one patient with CVI. Moreover, we found no differences in the number of blood transfusions, surgical procedures, or administrations of intravenous or intramuscular immunoglobulin between HCV RNA-positive and HCV RNA-negative groups. We concluded that: (1) the incidence of HCV infection in patients with hypogammaglobulinemia is much higher than that reported in the Italian general population; (2) although patients with hypogammaglobulinemia have persistent viremia, they do not show an aggressive course of HCV disease, nor does hepatocarcinoma develop; and (3) intravenous immunoglobulins are only one of several possible causes of HCV transmission in patients with humoral immunodeficiencies.

Original languageEnglish
Pages (from-to)96-107
Number of pages12
JournalClinical Therapeutics
Volume18
Issue numberSUPPL. B
DOIs
Publication statusPublished - 1996

Fingerprint

Agammaglobulinemia
Virus Diseases
Hepacivirus
Common Variable Immunodeficiency
Immunoglobulins
Ataxia Telangiectasia
Viremia
Intravenous Immunoglobulins
RNA
Wiskott-Aldrich Syndrome
Passive Immunization
Chronic Hepatitis
Alanine Transaminase
Blood Transfusion
Intravenous Administration
Immunoglobulin G

ASJC Scopus subject areas

  • Pharmacology

Cite this

Quinti, I., Pandolfi, F., Paganelli, R., Giovannetti, A., Sacco, G., Oliva, A., & Aiuti, F. (1996). Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. Clinical Therapeutics, 18(SUPPL. B), 96-107. https://doi.org/10.1016/S0149-2918(96)80201-3

Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. / Quinti, Isabella; Pandolfi, Franco; Paganelli, Roberto; Giovannetti, Antonello; Sacco, Giovanna; Oliva, Alessandra; Aiuti, Fernando.

In: Clinical Therapeutics, Vol. 18, No. SUPPL. B, 1996, p. 96-107.

Research output: Contribution to journalArticle

Quinti, I, Pandolfi, F, Paganelli, R, Giovannetti, A, Sacco, G, Oliva, A & Aiuti, F 1996, 'Hepatitis C virus infection in Italian patients with hypogammaglobulinemia', Clinical Therapeutics, vol. 18, no. SUPPL. B, pp. 96-107. https://doi.org/10.1016/S0149-2918(96)80201-3
Quinti, Isabella ; Pandolfi, Franco ; Paganelli, Roberto ; Giovannetti, Antonello ; Sacco, Giovanna ; Oliva, Alessandra ; Aiuti, Fernando. / Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. In: Clinical Therapeutics. 1996 ; Vol. 18, No. SUPPL. B. pp. 96-107.
@article{5faa09bede304916a8fa92e979d90ff0,
title = "Hepatitis C virus infection in Italian patients with hypogammaglobulinemia",
abstract = "We investigated the presence of hepatitis C virus (HCV) infection in 58 patients with humoral immunodeficiencies. Forty-three of these patients had common variable immunodeficiency (CVI), 2 had sporadic hyperimmunoglobulin M (HIM) syndrome, 2 had immunoglobulin C subclass deficiency, 4 had ataxia-telangiectasia (AT), and 7 had X-linked agammaglobulinemia (XLA). Patients with late-onset hypogammaglobulinemia (those with CVI, HIM, or immunoglobulin G subclass deficiency) had a 38.2{\%} prevalence of HCV infection. In patients with XLA or AT, HCV infection was not detectable. Most of the HCV-infected patients had persistent viremia, with histologic findings of chronic hepatitis. Although patients positive for HCV ribonucleic acid (RNA) had received several lots of immunoglobulin, we were unable to detect any correlation between the time that alanine aminotransferase levels increased and the time that intravenous immunoglobulin therapy was given, except in one patient with CVI. Moreover, we found no differences in the number of blood transfusions, surgical procedures, or administrations of intravenous or intramuscular immunoglobulin between HCV RNA-positive and HCV RNA-negative groups. We concluded that: (1) the incidence of HCV infection in patients with hypogammaglobulinemia is much higher than that reported in the Italian general population; (2) although patients with hypogammaglobulinemia have persistent viremia, they do not show an aggressive course of HCV disease, nor does hepatocarcinoma develop; and (3) intravenous immunoglobulins are only one of several possible causes of HCV transmission in patients with humoral immunodeficiencies.",
author = "Isabella Quinti and Franco Pandolfi and Roberto Paganelli and Antonello Giovannetti and Giovanna Sacco and Alessandra Oliva and Fernando Aiuti",
year = "1996",
doi = "10.1016/S0149-2918(96)80201-3",
language = "English",
volume = "18",
pages = "96--107",
journal = "Clinical Therapeutics",
issn = "0149-2918",
publisher = "Excerpta Medica Inc.",
number = "SUPPL. B",

}

TY - JOUR

T1 - Hepatitis C virus infection in Italian patients with hypogammaglobulinemia

AU - Quinti, Isabella

AU - Pandolfi, Franco

AU - Paganelli, Roberto

AU - Giovannetti, Antonello

AU - Sacco, Giovanna

AU - Oliva, Alessandra

AU - Aiuti, Fernando

PY - 1996

Y1 - 1996

N2 - We investigated the presence of hepatitis C virus (HCV) infection in 58 patients with humoral immunodeficiencies. Forty-three of these patients had common variable immunodeficiency (CVI), 2 had sporadic hyperimmunoglobulin M (HIM) syndrome, 2 had immunoglobulin C subclass deficiency, 4 had ataxia-telangiectasia (AT), and 7 had X-linked agammaglobulinemia (XLA). Patients with late-onset hypogammaglobulinemia (those with CVI, HIM, or immunoglobulin G subclass deficiency) had a 38.2% prevalence of HCV infection. In patients with XLA or AT, HCV infection was not detectable. Most of the HCV-infected patients had persistent viremia, with histologic findings of chronic hepatitis. Although patients positive for HCV ribonucleic acid (RNA) had received several lots of immunoglobulin, we were unable to detect any correlation between the time that alanine aminotransferase levels increased and the time that intravenous immunoglobulin therapy was given, except in one patient with CVI. Moreover, we found no differences in the number of blood transfusions, surgical procedures, or administrations of intravenous or intramuscular immunoglobulin between HCV RNA-positive and HCV RNA-negative groups. We concluded that: (1) the incidence of HCV infection in patients with hypogammaglobulinemia is much higher than that reported in the Italian general population; (2) although patients with hypogammaglobulinemia have persistent viremia, they do not show an aggressive course of HCV disease, nor does hepatocarcinoma develop; and (3) intravenous immunoglobulins are only one of several possible causes of HCV transmission in patients with humoral immunodeficiencies.

AB - We investigated the presence of hepatitis C virus (HCV) infection in 58 patients with humoral immunodeficiencies. Forty-three of these patients had common variable immunodeficiency (CVI), 2 had sporadic hyperimmunoglobulin M (HIM) syndrome, 2 had immunoglobulin C subclass deficiency, 4 had ataxia-telangiectasia (AT), and 7 had X-linked agammaglobulinemia (XLA). Patients with late-onset hypogammaglobulinemia (those with CVI, HIM, or immunoglobulin G subclass deficiency) had a 38.2% prevalence of HCV infection. In patients with XLA or AT, HCV infection was not detectable. Most of the HCV-infected patients had persistent viremia, with histologic findings of chronic hepatitis. Although patients positive for HCV ribonucleic acid (RNA) had received several lots of immunoglobulin, we were unable to detect any correlation between the time that alanine aminotransferase levels increased and the time that intravenous immunoglobulin therapy was given, except in one patient with CVI. Moreover, we found no differences in the number of blood transfusions, surgical procedures, or administrations of intravenous or intramuscular immunoglobulin between HCV RNA-positive and HCV RNA-negative groups. We concluded that: (1) the incidence of HCV infection in patients with hypogammaglobulinemia is much higher than that reported in the Italian general population; (2) although patients with hypogammaglobulinemia have persistent viremia, they do not show an aggressive course of HCV disease, nor does hepatocarcinoma develop; and (3) intravenous immunoglobulins are only one of several possible causes of HCV transmission in patients with humoral immunodeficiencies.

UR - http://www.scopus.com/inward/record.url?scp=0029912807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029912807&partnerID=8YFLogxK

U2 - 10.1016/S0149-2918(96)80201-3

DO - 10.1016/S0149-2918(96)80201-3

M3 - Article

C2 - 8930447

AN - SCOPUS:0029912807

VL - 18

SP - 96

EP - 107

JO - Clinical Therapeutics

JF - Clinical Therapeutics

SN - 0149-2918

IS - SUPPL. B

ER -